CVS Q3 Tops Estimates as Retail Revenues Gain

CVS Q3 Tops Estimates as Retail Revenues Gain

Third quarter earnings and income at CVS Health beat Wall Street estimates despite unadjusted losses from an opioid litigation settlement. Company net loss was $3.42 billion, or $2.60 per diluted share, versus net income of $1.6 billion, or $1.20 per diluted share, in...